Vivaldi Capital Management LP - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 107 filers reported holding UROGEN PHARMA LTD in Q4 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
Vivaldi Capital Management LP ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q2 2024$337,681
+31.7%
20,1240.0%0.10%
+28.0%
Q1 2024$256,380
-16.9%
20,124
+22.3%
0.08%
-19.4%
Q4 2023$308,644
+33.8%
16,4610.0%0.09%
+24.0%
Q3 2023$230,619
+93.8%
16,461
+43.1%
0.08%
+102.7%
Q2 2023$119,025
-57.5%
11,500
-30.9%
0.04%
-39.3%
Q3 2021$280,000
+20.2%
16,650
+66.5%
0.06%
+17.3%
Q3 2020$233,000
-8.6%
10,000
-9.1%
0.05%
-1.9%
Q2 2020$255,00011,0000.05%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2023
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 1,155,862$38,571,00011.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 849,478$28,347,0004.49%
Horton Capital Management, LLC 108,670$3,626,0003.53%
Prosight Management, LP 217,686$7,264,0003.19%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$98,598,0002.35%
Phoenix Holdings Ltd. 834,739$27,663,0001.16%
SHIKIAR ASSET MANAGEMENT INC 67,025$2,237,0000.74%
MEITAV INVESTMENT HOUSE LTD 272,063$9,080,0000.66%
Clal Insurance Enterprises Holdings Ltd 17,666$529,388,0000.57%
Migdal Insurance & Financial Holdings Ltd. 738,302$24,637,0000.48%
View complete list of UROGEN PHARMA LTD shareholders